Browse through the entire archive of MasterControl news articles.
Responsible data handling, the impact of mishandling data, and how
organizations can implement ethical data best practices.
In January 2020, Sumitomo Dainippon Pharma, a pharmaceutical company based in
Osaka, Japan, and Exscientia, an artificial intelligence (AI) drug discovery
company based in Oxford, United Kingdom, initiated a Phase I clinical study of
DSP-1181.
This is one example of AI-based products converging on the regulatory pathways
toward mainstream health care.
Read the full article
HERE.